CytomX Therapeutics: Q1 Earnings Insights

CytomX Therapeutics CTMX reported its Q1 earnings results on Thursday, May 5, 2022 at 04:15 PM.

Here's what investors need to know about the announcement.

CytomX Therapeutics missed estimated earnings by 2.78%, reporting an EPS of $-0.37 versus an estimate of $-0.36.

Revenue was up $1.17 million from the same period last year.

Last quarter the company missed on EPS by $0.12 which was followed by a 14.12% increase in the share price the next day.

Here's a look at CytomX Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.28	-0.31	-0.32	-0.35
EPS Actual	-0.40	-0.35	-0.30	-0.26
Revenue Estimate	24.51M	18.08M	16.86M	15.43M
Revenue Actual	19.73M	17.59M	16.29M	15.97M

To track all earnings releases for CytomX Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar